Invention Grant
- Patent Title: Chimeric engulfment receptor molecules
-
Application No.: US17400082Application Date: 2021-08-11
-
Publication No.: US11655282B2Publication Date: 2023-05-23
- Inventor: Daniel Mark Corey
- Applicant: CERO THERAPEUTICS, INC.
- Applicant Address: US CA South San Francisco
- Assignee: CERO THERAPEUTICS, INC.
- Current Assignee: CERO THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Seed Intellectual Property Law Group LLP
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K14/47 ; C07K14/735 ; C07K16/28 ; C07K16/30 ; C12N9/12 ; A61K38/00 ; A61K39/00 ; A61P35/00 ; A61K35/17 ; C07K14/535
Abstract:
The present disclosure relates to chimeric engulfment receptor molecules, host cells modified to include the phagocytic engulfment molecules, and methods of making and using such receptor molecules and modified cells.
Public/Granted literature
- US20220098273A1 CHIMERIC ENGULFMENT RECEPTOR MOLECULES Public/Granted day:2022-03-31
Information query
